Send mail to Author

An open-label trial of 12-week Simeprevir plus Peginterferon/Ribavirin (PR) in treatment-naïve patients with hepatitis C Virus (HCV) genotype 1 (GT1) (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _      ___     _    _     _____     ______    _____   
| \  / ||   / _ \\  | || | ||  |  ___||  /_   _//  |  ___|| 
|  \/  ||  | / \ || | || | ||  | ||__      | ||    | ||__   
| .  . ||  | \_/ || | \\_/ ||  | ||__     _| ||    | ||__   
|_|\/|_||   \___//   \____//   |_____||  /__//     |_____|| 
`-`  `-`    `---`     `---`    `-----`   `--`      `-----`
 


Back to frontdoor view

OPUS4 Logo